Takara Bio, Inc. is engaged in the development and marketing of genetic engineering technologies. It operates through the following business segments: Genetic Engineering Research, AgriBio, and Gene Medicine. The Genetic Engineering Research segment offers research reagents, scientific instruments, and contract research services that are essential for biotechnology research. The AgriBio segment develops a business centered in technologies for the production of health food products and mushrooms, including Hatakashimeji and Honshimeji mushrooms. The Gene Medicine segment conducts clinical development projects as it works toward commercializing cell and gene therapies centered on gene transduction method and a lymphocyte expansion culture systems. The company was founded on April 1, 2002 and is headquartered in Otsu, Japan.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.